-transparent.png){kind=logo}
The use of electrical energy for the immediate treatment of atrial and ventricular arrhythmias is practical and easily applied. The method, though simple, is the most effective method for terminating cardiac arrhythmias and is associated with only a low risk if properly employed. In symptomatic patients, the utilization of cardioversion reduces patient discomfort and complications which may occur while awaiting pharmacologic reversion of arrhythmia. At present, transthoracic defibrillation is the only practical method for terminating VF. Despite the safety of electrical reversion, proper precautions are necessary to prevent complications. In particular, the discharge of excessive energies, especially in the presence of digitalis toxicity, promises grave and life-threatening consequences. The use of antiarrhythmic medications is not supplanted by cardioversion and defibrillation. Rather, ongoing drug therapy is frequently necessary to prevent recurrence of arrhythmia.
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
October 1992,
Critical care clinics,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
August 2002,
Cardiovascular research,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
January 2005,
Medicina (Kaunas, Lithuania),
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
January 1991,
Pediatric nursing,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
October 2007,
Swiss medical weekly,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
January 2001,
Current opinion in cardiology,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
April 1980,
Orvosi hetilap,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
January 1994,
Heart disease and stroke : a journal for primary care physicians,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
January 2005,
Zhonghua xin xue guan bing za zhi,
R A DeSilva, and
T B Graboys, and
P J Podrid, and
B Lown
April 2023,
Orvosi hetilap,
